Event Start Date | 06-15-2023 |
Event End Date | 06-15-2023 |
Location | Sheraton San Diego Hotel & Marina |
Categories | UHMS Directly Provided Course |
0800-0815 |
Andrew Melnyczenko, CHTWelcome/Introduction to the course |
0815-0900 |
Gary Toups, MDBurning Down the Bandwagon—The Catastrophic Potential of a Casual Approach to Hyperbaric Safety |
0900-0945 |
Col. Jason Kelly, MDOn-label safety for off-label therapy: Approaches to the delivery of hyperbaric oxygen therapy for off-label indications. The off-label use of medications is a widely accepted and common practice, involving as many as 20% of prescriptions provided in the United States. The provision of off-label Hyperbaric Oxygen Therapy is equally as prevalent but remains controversial within the field. This presentation will examine how the use of Hyperbaric Oxygen Therapy is regulated and what differentiates on-label and off-label therapy. It will provide guidance on how to assess the safety of providing off-label therapy and mitigation strategies for any unique risks. |
0945-1030 |
Nicholas Marosek, CHRNApproaches to safety in the delivery of hyperbaric oxygen therapy to critical care patients |
1030-1045 |
BREAKBREAK |
1045-1130 |
Francois BurmanUnravelling our Hyperbaric Codes and Standards: The ongoing, real-time development of hyperbaric industry rules is intended to be transparent. Interested parties have access to either pre-published code revisions or standards committees and are welcomed to provide input. In most cases they may attend committee meetings to observe deliberations over suggested updates, revisions, and even new materials. The committees that develop these publications are made up of a balanced number of individuals representing all aspects of our industry: medicine, engineering and technology, operational management, design and manufacture, research, and governmental institutions. Despite all of this, most of our colleagues regard regulatory documents as strict compliance mandates, often formulated either by parties with their own interests, or administrative organizations with little or no knowledge of our field. This presentation will hopefully peel back some of the layers to allay such concerns and ultimately invite more participation by all hyperbaric industry stakeholders. |
1130-1200 |
Derall Garrett, CHTThe AHJ. Who are they? |
11200-1300 |
LUNCH BREAKLUNCH BREAK - ON OWN |
1300-1345 |
Richard C. Barry, Ph.D., STS, CHT-AdminWhere to defibrillate – In the HBO Room or Not? |
1345-1430 |
Anthony Johnston, ACHRNHyperbaric staff competencies |
1430-1530 |
Rob Sheffield, CHTChecklists, complacency, and human nature |
1530-1545 |
BREAKBREAK |
1545-1630 |
Roma Tremblay, APRNRetrospective analysis of monoplace and multiplace chamber accidents |
1630-1715 |
Matthew Kelly, MDHyperbaric Medicine Emergencies: Description: This lecture is to review emergent hyperbaric medicine conditions, and why HBO may benefit these patients. There will be a Quick review of the pathophysiology of HBOT and how it can affect these conditions given many of the UHMS approved indications are for emergent medical and surgical conditions. Many patients with emergency conditions are clinically stable, and treatment for these patients can be easily performed in monoplace and multiplace hyperbaric chambers. |
1715-1730 |
Andrew Melnyczenko, CHTQuestions/ Course Evaluation / Closing |